{"id":{"repo_id":"duquesne","oai_identifier":"oai:dsc.duq.edu:etd-3002"},"canonical_url":"https://search.ndltd.org/etd/duquesne/oai:dsc.duq.edu:etd-3002","repository":{"repo_id":"duquesne","name":"Duquesne","base_url":"https://dsc.duq.edu/do/oai/"},"display":{"title":"Diagnosis of Melanoma Disease State From Patient Blood Samples Using Photoacoustic Flow Cytometry","abstract":"Approximately 1 in 50 Americans develop melanoma in their lifetime. Early detection of melanoma is pivotal to the survival of the patient, with a 99% survival rate for 5 or more years after an early diagnosis. Metastasis, or the spread of cancer, increases the chances of cancerous growth in other parts of the body. In this study, we propose the use of photoacoustic flow cytometry as a diagnostic of patient disease state, by closely monitoring the amount of circulating melanoma cells (CMCs) in a patient’s blood before and after chemotherapy treatments. Using this patient data, we were able to make conclusions regarding the progression of cancer in each of the patients. In the future, we hope to use this real time diagnostic as insight to the effectiveness of a patient’s treatment and ideally sculpting a more effective patient- by- patient treatment regimen.","abstract_html":"Approximately 1 in 50 Americans develop melanoma in their lifetime. Early detection of melanoma is pivotal to the survival of the patient, with a 99% survival rate for 5 or more years after an early diagnosis. Metastasis, or the spread of cancer, increases the chances of cancerous growth in other parts of the body. In this study, we propose the use of photoacoustic flow cytometry as a diagnostic of patient disease state, by closely monitoring the amount of circulating melanoma cells (CMCs) in a patient’s blood before and after chemotherapy treatments. Using this patient data, we were able to make conclusions regarding the progression of cancer in each of the patients. In the future, we hope to use this real time diagnostic as insight to the effectiveness of a patient’s treatment and ideally sculpting a more effective patient- by- patient treatment regimen.","abstract_has_math":false,"creators":["Salvatore, Jacob"],"institution":null,"degree_name":"MS","degree_level":"Immediate Access","degree_discipline":"Biomedical Engineering","degree_department":null,"school":null,"contributors":["John Viator","Melikhan Tanyeri","John Kern"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T07:51:32Z","subjects":["Melanoma","Photoacoustics","Detection","Cancer","Disease-State","Flow Cytometry","Bioimaging and Biomedical Optics","Biomedical Devices and Instrumentation","Biomedical Engineering and Bioengineering","Molecular, Cellular, and Tissue Engineering"],"languages":["English"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://dsc.duq.edu/etd/1994","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://dsc.duq.edu/etd/1994","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://dsc.duq.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adsc.duq.edu%3Aetd-3002","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["John Viator","Melikhan Tanyeri","John Kern"]},{"key":"dc:creator","label":"Author","values":["Salvatore, Jacob"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2021-05-07T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2021-05-07T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biomedical Engineering"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Immediate Access"]},{"key":"thesis:degree_name","label":"Degree Name","values":["MS"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Melanoma","Photoacoustics","Detection","Cancer","Disease-State","Flow Cytometry","Bioimaging and Biomedical Optics","Biomedical Devices and Instrumentation","Biomedical Engineering and Bioengineering","Molecular, Cellular, and Tissue Engineering"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://dsc.duq.edu/etd/1994"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Approximately 1 in 50 Americans develop melanoma in their lifetime. Early detection of melanoma is pivotal to the survival of the patient, with a 99% survival rate for 5 or more years after an early diagnosis. Metastasis, or the spread of cancer, increases the chances of cancerous growth in other parts of the body. In this study, we propose the use of photoacoustic flow cytometry as a diagnostic of patient disease state, by closely monitoring the amount of circulating melanoma cells (CMCs) in a patient’s blood before and after chemotherapy treatments. Using this patient data, we were able to make conclusions regarding the progression of cancer in each of the patients. In the future, we hope to use this real time diagnostic as insight to the effectiveness of a patient’s treatment and ideally sculpting a more effective patient- by- patient treatment regimen."]},{"key":"dc:title","label":"Title","values":["Diagnosis of Melanoma Disease State From Patient Blood Samples Using Photoacoustic Flow Cytometry"]}]}],"canonical_facts":{"dc:contributor":["John Viator","Melikhan Tanyeri","John Kern"],"dc:creator":["Salvatore, Jacob"],"dc:date.available":["2021-05-07T07:00:00Z"],"dc:date.created":["2021-05-07T07:00:00Z"],"dc:description.abstract":["Approximately 1 in 50 Americans develop melanoma in their lifetime. Early detection of melanoma is pivotal to the survival of the patient, with a 99% survival rate for 5 or more years after an early diagnosis. Metastasis, or the spread of cancer, increases the chances of cancerous growth in other parts of the body. In this study, we propose the use of photoacoustic flow cytometry as a diagnostic of patient disease state, by closely monitoring the amount of circulating melanoma cells (CMCs) in a patient’s blood before and after chemotherapy treatments. Using this patient data, we were able to make conclusions regarding the progression of cancer in each of the patients. In the future, we hope to use this real time diagnostic as insight to the effectiveness of a patient’s treatment and ideally sculpting a more effective patient- by- patient treatment regimen."],"dc:identifier":["https://dsc.duq.edu/etd/1994"],"dc:language":["English"],"dc:subject":["Melanoma","Photoacoustics","Detection","Cancer","Disease-State","Flow Cytometry","Bioimaging and Biomedical Optics","Biomedical Devices and Instrumentation","Biomedical Engineering and Bioengineering","Molecular, Cellular, and Tissue Engineering"],"dc:title":["Diagnosis of Melanoma Disease State From Patient Blood Samples Using Photoacoustic Flow Cytometry"],"thesis:degree_discipline":["Biomedical Engineering"],"thesis:degree_level":["Immediate Access"],"thesis:degree_name":["MS"]},"updated_at":"2026-11-19T07:51:32Z"}